The VanEck Pharmaceutical ETF enters the week with borrow availability caught in a notable squeeze — and short interest holding near a month-long high relative to the float.
The lending market tells the more interesting story here. Availability tightened sharply through mid-May, dropping to a low of roughly 20% on May 13 — meaning only one share was available to borrow for every five already out on loan. That is well inside "very tight" territory, and marks a dramatic shift from late April, when availability ran above 150%. The recovery to 44.5% by May 19 is real but still tight. Cost to borrow has drifted higher too, running at 4.26% APR and roughly 10% above where it was a week ago, having briefly touched 5.1% on May 18. The 52-week availability trough reached as low as 10.2%, so the current level has room to tighten further.
Short interest against the free float sits at approximately 2.4% — a modest absolute level, but the direction of travel through April and early May was upward. From mid-April, when shorts were closer to 2.1–2.2% of float, positions climbed steadily before pulling back this week, falling around 6% over the last five trading days. The ORTEX short score remains elevated at 73.2 out of 100, broadly in line with where it has held for the past two weeks. That persistently high reading signals that the overall short-setup — combining short interest level, borrow cost, and availability — remains charged even as the headline shares-short figure retreats.
Options positioning meanwhile leans the other way. Calls dominate the flow. The put/call ratio has dropped to 0.18, which is near the 52-week low of 0.17 and roughly 1.4 standard deviations below its 20-day average of 0.21. That gap between a cautious borrow market and a bullish options market is the week's defining tension. Investors are buying calls while the lending pool tightens — a split verdict on near-term direction.
On the ownership side, the Q1 13-F disclosures show some notable shifts. Jane Street entered a fresh position of 811,000 shares — a clean new build. The Employees Retirement System of Texas added 531,600 shares from scratch. On the other side, Citigroup cut its position by over 1.1 million shares, the largest single reduction in the top-15 holder list. Goldman Sachs, the largest disclosed holder at 32.5% of reported shares, added roughly 169,000 shares. The net picture from the institutional side is one of active repositioning rather than broad conviction in either direction.
The ETF itself closed at $102.46, up 1.3% on the day and 1.3% on the week, clawing back part of a 2% decline over the past month. With no earnings events for an ETF structure and sector-level newsflow dictating the price action, what to watch is whether the recent loosening of borrow availability continues — or whether demand for shorts rebuilds and drives availability back toward the mid-May trough.
See the live data behind this article on ORTEX.
Open PPH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
